Company name Keysight Technologies Inc
Stock ticker KEYS
Live stock price [stckqut]KEYS[/stckqut]
P/E compared to competitors Good

 

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Fair
EPS growth Good
P/E growth Good
EBITDA growth Good
Price growth Good
R&D growth Fair
Income growth Good
Assets growth Good
Return on Assets growth Good
Market Capitalization Growth Good
Income / Rev growth Good
TWCA Plus Good
Standard TWCA Good
Weighted ann. stock price increase Good

 

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $151.47
Target stock price (averages with growth) $226.48
Target stock price (averages with no growth) $130.04
Target stock price (manual assumptions) $140.84

 

The following company description is from Stockrow: https://stockrow.com/KEYS

Keysight Technologies, Inc. provides electronic design and test solutions to commercial communications, networking, aerospace, defense and government, automotive, energy, semiconductor, electronic, and education industries in the Americas, Europe, and the Asia Pacific regions. Its Communications Solutions Group segment provides electronic design automation (EDA) software; and radio frequency and microwave test instruments; oscilloscopes, logic and serial protocol analyzers, logic-signal sources, arbitrary waveform generators, and bit error rate testers; optical modulation analyzers, optical component analyzers, optical power meters, and optical laser source solutions; and repair, calibration, and consulting services, as well as resells refurbished used Keysight equipment. The company’s Electronic Industrial Solutions Group segment offers design tools; design verification solutions; digital multi-meters, function generators, frequency counters, data acquisition systems, audio analyzers, LCR meters, thermal imagers, precision source measure units, ultra-high precision device current analyzers, and test executive software platforms, as well as various power supplies comprising AC/DC modular supplies and electronically programmable loads. This segment also provides printed-circuit-board-assembly testers, integrated circuit parametric testers, and sub-nano-meter positioning sub-assemblies; test and measurement products and software; and repair, calibration, and consulting services, as well as resells refurbished used Keysight equipment. Its Ixia Solutions Group segment offers software applications and services, including warranty and maintenance offerings, and hardware platforms. The company sells its products through direct sales force, distributors, resellers, and manufacturer’s representatives. It has partnership with Qualcomm Technologies, Inc. The company was incorporated in 2013 and is headquartered in Santa Rosa, California.

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Keysight Technologies Inc as long as the indicators that I describe in my book The Confident Investor are favorable.

 

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Keysight Technologies Inc calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $98.13
  • Growth: 0.151413882105943
  • Current EPS (TTM): $3.59667
  • P/E: 31.162655699453
  • Future EPS Calc: $7.27
  • Future Stock Price Calc: $226.82
  • Target stock price: $140.84

[/s2If]
I hope that this makes you a Confident Investor.

 

Company name China Biologic Products Holdings Inc
Stock ticker CBPO
Live stock price [stckqut]CBPO[/stckqut]
P/E compared to competitors Fair

 

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Fair
EPS growth Good
P/E growth Poor
EBIT growth Good
Price growth Good
R&D growth Fair
Income growth Good
Assets growth Good
Return on Assets growth Poor
Income / Rev growth Fair
TWCA Plus Good
Standard TWCA Good
Weighted ann. stock price increase Poor

 

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $169.48
Target stock price (averages with growth) $120.38
Target stock price (averages with no growth) $119.75
Target stock price (manual assumptions) $128.17

 

The following company description is from Reuters: https://finance.yahoo.com/quote/cbpo/profile?p=cbpo

China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People’s Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also provides human immunoglobulin and IVIG for original and secondary immunoglobulin deficiency, and immunoglobulin G secondary deficiency; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus. In addition, it offers placenta polypeptide for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia, as well as assists in postoperative healing; factor VIII for treating coagulopathies; human fibrinogen; and human prothrombin complex concentrate for treating congenital and acquired clotting factor II, VII, IX, X deficiency, as well as excessive anticoagulant, vitamin K deficiency, etc. Further, the company is developing Human fibrinogen for the treatment for lack of fibrinogen and increase human fibrinogen concentration; and artificial dura and spinal dura mater products for use in brain and spinal surgeries. The company sells its products directly, as well as through distributors. The company was formerly known as China Biologic Products, Inc. and changed its name to China Biologic Products Holdings, Inc. in July 2017. China Biologic Products Holdings, Inc. is headquartered in Beijing, the People’s Republic of China.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in China Biologic Products Holdings Inc as long as the price is correct and the indicators that I describe in my book The Confident Investor are favorable. Most of the fundamentals of this company are good but there are some concerns. I am removing China Biologic from my Watch List due to its recent stock performance and the current climate of reducing the importance of companies from China in western markets. This will make room for stocks that are higher performing.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of China Biologic Products Holdings Inc calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $109.64
  • Growth: 0.1647
  • Current EPS (TTM): $3.64833333333333
  • P/E: 26.3983823385159
  • Future EPS Calc: $7.81
  • Future Stock Price Calc: $206.41
  • Target stock price: $128.16

[/s2If]
I hope that this makes you a Confident Investor.

 

Company name Cirrus Logic, Inc.
Stock ticker CRUS
Live stock price [stckqut]CRUS[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Poor
EPS growth Good
P/E growth Good
EBIT growth Poor

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $41.38
Target stock price (averages with growth) $44.41
Target stock price (averages with no growth) $44.41
Target stock price (manual assumptions) $41.54

 

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/crus

Cirrus Logic, Inc., incorporated on August 26, 1998, is engaged in providing integrated circuits (ICs) for audio and voice signal processing applications. The Company develops analog and mixed-signal ICs for a range of customers. The Company offers two product lines: Portable Audio, and Non-Portable Audio and Other. The Company’s products span the entire audio signal chain, from capture to playback, providing products for a range of smartphones, tablets, digital headsets, wearables and smart home applications. The Company’s primary facility housing engineering, sales and marketing, and administration functions is located in Austin, Texas. The Company offers products through both direct and indirect sales channels across the world.

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Cirrus Logic, Inc. as long as the price is correct and the indicators that I describe in my book The Confident Investor are favorable. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Cirrus Logic, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $38.05
  • Growth: 0.12
  • Current EPS (TTM): $1.46
  • P/E: 26
  • Future EPS Calc: $2.57
  • Future Stock Price Calc: $66.89
  • Target stock price: $41.53

[/s2If]
I hope that this makes you a Confident Investor.

 

Company name China Biologic Products Holdings Inc
Stock ticker CBPO
Live stock price [stckqut]CBPO[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $139.17
Target stock price (averages with growth) $95.37
Target stock price (averages with no growth) $95.37
Target stock price (manual assumptions) $107.17

 

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/cbpo

China Biologic Products Holdings, Inc. is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates through the manufacture and sales of human plasma products segment. China Biologic has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across nine categories.

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in China Biologic Products Holdings Inc as long as the indicators that I describe in my book The Confident Investor are favorable.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of China Biologic Products Holdings Inc calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $89.93
  • Growth: 0.14
  • Current EPS (TTM): $3.32
  • P/E: 27
  • Future EPS Calc: $6.39
  • Future Stock Price Calc: $172.59
  • Target stock price: $107.16

[/s2If]
I hope that this makes you a Confident Investor.

Company name Hudson Technologies, Inc.
Stock ticker HDSN
Live stock price [stckqut]HDSN[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $4.87
Target stock price (averages with growth) $3.32
Target stock price (averages with no growth) $2.25
Target stock price (manual assumptions) $.65

 

The following company description is from Reuters: https://www.reuters.com/finance/stocks/company-profile/hdsn

Hudson Technologies, Inc., incorporated on January 11, 1991, is a refrigerant services company. The Company’s products and services are primarily used in commercial air conditioning, industrial processing, and refrigeration systems, and include refrigerant and industrial gas sales, refrigerant management services consisting primarily of reclamation of refrigerants and RefrigerantSide Services performed at a customer’s site, consisting of system decontamination to remove moisture, oils and other contaminants. In addition, the Company’s SmartEnergy OPS service is a Web-based real-time continuous monitoring service applicable to a facility’s refrigeration systems and other energy systems. The Company’s Chiller Chemistry and Chill Smart services are also predictive and diagnostic service offerings. The Company sells reclaimed and virgin (new) refrigerants to a variety of customers in various segments of the air conditioning and refrigeration industry, and sells industrial gases to a variety of industry segments.

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Hudson Technologies, Inc. as long as the price is correct. Most of the fundamentals of Hudson Technologies, Inc. are good, in fact, the company ranks as a Good company, but there are some concerns about the price of the stock. I am removing the stock from my Watch List.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Hudson Technologies, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $2.4
  • Growth: 0.2
  • Current EPS (TTM): $0.02
  • P/E: 21
  • Future EPS Calc: $0.04
  • Future Stock Price Calc: $1.04
  • Target stock price: $0.64

[/s2If]
I hope that this makes you a Confident Investor.